Hubei Jumpcan Pharmaceutical Co., Ltd. (SHA: 600566)
China flag China · Delayed Price · Currency is CNY
31.68
-0.17 (-0.53%)
Nov 13, 2024, 3:00 PM CST

Hubei Jumpcan Pharmaceutical Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Net Income
2,7812,8232,1711,7191,2771,623
Upgrade
Depreciation & Amortization
298.26298.26308.8293.81280.95232.5
Upgrade
Other Amortization
6.466.469.4910.257.122.54
Upgrade
Loss (Gain) From Sale of Assets
-0.13-0.13-5.22-0.65-3.35-0.3
Upgrade
Asset Writedown & Restructuring Costs
1.091.090.530.420.771.96
Upgrade
Loss (Gain) From Sale of Investments
-96.33-96.33-58.89-161.53-22.31-22.31
Upgrade
Provision & Write-off of Bad Debts
-3.04-3.0436.028.286.230.29
Upgrade
Other Operating Activities
-1,05721.6831.7532.7733.0530.74
Upgrade
Change in Accounts Receivable
22.8122.81-713.7-181.1915.2528.72
Upgrade
Change in Inventory
-98.6-98.6-15.89-97.1760.05-20.31
Upgrade
Change in Accounts Payable
476.51476.51856.54269.4489.94250.99
Upgrade
Change in Other Net Operating Assets
8.528.52-4.07-6.2431.16-2.26
Upgrade
Operating Cash Flow
2,3443,4642,6211,8941,7822,148
Upgrade
Operating Cash Flow Growth
-32.23%32.17%38.35%6.32%-17.04%25.66%
Upgrade
Capital Expenditures
-207.7-301.64-243.66-248.32-429.63-546.44
Upgrade
Sale of Property, Plant & Equipment
1.047.9852.820.791.540.68
Upgrade
Divestitures
----35.5-
Upgrade
Investment in Securities
-2,709-182.68-1,380-474.89-1,09689
Upgrade
Other Investing Activities
38.5182.1267.5349.117.612.31
Upgrade
Investing Cash Flow
-2,877-394.23-1,503-673.3-1,481-444.46
Upgrade
Short-Term Debt Issued
-1,095400---
Upgrade
Total Debt Issued
1,6371,095400---
Upgrade
Short-Term Debt Repaid
--400-7.52-0--
Upgrade
Long-Term Debt Repaid
--1.48-1.79-1.82-0-0
Upgrade
Total Debt Repaid
-1,003-401.48-9.31-1.82-0-0
Upgrade
Net Debt Issued (Repaid)
634.28693.96390.69-1.82-0-0
Upgrade
Issuance of Common Stock
25.5314.2197.18501,405-
Upgrade
Repurchase of Common Stock
-35.67-35.67----
Upgrade
Common Dividends Paid
-1,221-823.19-605.45-409.37-1,009-1,005
Upgrade
Other Financing Activities
-22.24----22.41-
Upgrade
Financing Cash Flow
-619.44-150.69-117.58-361.19373.8-1,005
Upgrade
Net Cash Flow
-1,1532,919999.94859.84674.34697.91
Upgrade
Free Cash Flow
2,1363,1622,3771,6461,3521,601
Upgrade
Free Cash Flow Growth
-32.32%33.03%44.42%21.74%-15.56%53.80%
Upgrade
Free Cash Flow Margin
23.94%32.75%26.42%21.57%21.93%23.07%
Upgrade
Free Cash Flow Per Share
2.323.452.621.831.621.96
Upgrade
Cash Income Tax Paid
1,5901,6501,2641,177926.31,090
Upgrade
Levered Free Cash Flow
1,3642,2781,6401,012908.931,302
Upgrade
Unlevered Free Cash Flow
1,3832,2891,6591,034929.581,321
Upgrade
Change in Net Working Capital
426.78-470.31-170.9265.76-205.39-506.2
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.